Blog Detail
Onco'Zine - The international Cancer Blog
http://oncozine.blogspot.com
Onco’Zine - The International Cancer Blog, reports about current research and development in hematology and oncology and includes comments on peer-reviewed reports and congress reports from international medical meetings.
- Added on: Jun 23rd, 2009
- Country: United States
- Language: English
- Author: Peter Hofland, Phd
- Listed in: Medicine Life Science
- Tags: medicine Treatment Cancer oncology blood hematology
Recent Posts
Brachytherapy Used for the First Time in United States to Treat Lung Cancer
A 58-year-old man who lives in Corona, Queens came to the emergency room of New York Hospital Queens (NYHQ) with extreme pain and tingling in his left arm. Although he did not realize it at the time, he had lung cancer. Recently, he made medical hist...
Denosumab Superior to Zoledronic Acid in Reducing Incidence of Skeletal-Related Events in Breast Cancer Patients with Bone Metastases
Data Presented at earlier this month at the San Antonio Breast Cancer Symposium demonstrates that treatment with denosumab, a new drug in late stage clinical development, is superior to the standard of care in advanced breast cancer patients. Among ...
Bisphosphonates and the Risk of Postmenopausal Breast Cancer
Bisphosphonates are routinely given to women with postmenopausal breast cancer, but new data suggest that these agents may play an important role in reducing recurrent breast cancer as well. Results of a new trial demonstrated that the use of bisphos...
Oral Bisphosphonates May Significantly Reduce Breast Cancer
Results of a new analysis of data from the Women's Health Initiative (WHI) observational study showed that women who used bisphosphonates, which are commonly prescribed bone-strengthening pills, had significantly fewer invasive breast cancers than wo...
Final Follow-Up of Z-FAST Study Shows Zoledronic Acid May Benefit Postmenopausal Woman with Aromatase Inhibitor-Associated Bone Loss
Zoledronic acid is both safe and effective in preventing bone loss in postmenopausal women with breast cancer who are treated with aromatase inhibitors, according to data presented at the CTRC-AACR San Antonio Breast Cancer Symposium. "Women who...
New Drug Targeting Advanced Thymic Cancer May Bring Hope to Patients
The Translational Genomics Research Institute (TGen), a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking medical research in oncology, neurological disorders and diabetes, and Scottsdale Healthcare are testing a n...
